Male,n(%) |
106(77.9) |
Age at PCI,years(±SD) |
57.18±8.041 |
Body mass index,Kg/m2(±SD) |
23.91±1.456 |
Body surface area(m2) (±SD) |
1.70±0.207 |
Comorbidities |
|
hypertension,n(%) |
34(25.0) |
diabetes,n(%) |
27(19.8) |
Stoke/TIA |
14(10.2) |
hyperlipemia,n(%) |
23(16.9) |
Vessels with> 70% stenotic lesion |
|
LAD,n(%) |
106(77.9) |
LCX,n(%) |
20(14.7) |
RCA,n(%) |
39(28.7) |
Number of affected vessels≥2,n(%) |
41(30.1) |
Smoker,n(%) |
48(35.3) |
TC |
2.09±0.317 |
LDL |
2.20±0.436 |
NT-pro-BNP |
116(84,233) |
NYHA classification≥2,n(%) |
118(86.8) |
Medication post-PCI |
|
Aspirin,n(%) |
130(95.6) |
Clopidogrel,n(%) |
127(93.4) |
Beta blocker,n(%) |
122(89.7) |
Statin ,n(%) |
136(100) |
ACEI or ARB,n(%) |
126(92.6) |